C H van Dyck

2.8k total citations · 1 hit paper
12 papers, 2.1k citations indexed

About

C H van Dyck is a scholar working on Cellular and Molecular Neuroscience, Physiology and Psychiatry and Mental health. According to data from OpenAlex, C H van Dyck has authored 12 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cellular and Molecular Neuroscience, 3 papers in Physiology and 3 papers in Psychiatry and Mental health. Recurrent topics in C H van Dyck's work include Alzheimer's disease research and treatments (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Computational Drug Discovery Methods (2 papers). C H van Dyck is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Computational Drug Discovery Methods (2 papers). C H van Dyck collaborates with scholars based in United States and Canada. C H van Dyck's co-authors include Sami S. Zoghbi, Anissa Abi‐Dargham, Marc Laruelle, William H. Rosenblatt, Ronald M. Baldwin, Robert B. Innis, John Seibyl, Dennis S. Charney, Roberto Gil and Joseph Erdos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Schizophrenia Research.

In The Last Decade

C H van Dyck

11 papers receiving 2.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

1996 980 citations Marc Laruelle, Anissa Abi‐Dargham et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C H van Dyck United States	9	968	636	515	446	355	12	2.1k
Robert Perry United Kingdom	14	434 0.4×	436 0.7×	388 0.8×	396 0.9×	458 1.3×	19	1.9k
Ryosuke Arakawa Japan	28	746 0.8×	616 1.0×	241 0.5×	341 0.8×	530 1.5×	102	2.2k
Harumasa Takano Japan	27	589 0.6×	592 0.9×	418 0.8×	325 0.7×	601 1.7×	97	2.1k
Paul Ardayfio United States	14	359 0.4×	452 0.7×	920 1.8×	391 0.9×	146 0.4×	33	1.7k
Margaret A. Piggott United Kingdom	28	1.1k 1.1×	407 0.6×	666 1.3×	1.3k 3.0×	525 1.5×	55	2.9k
Ottavio V. Vitolo United States	20	1.0k 1.1×	284 0.4×	1.2k 2.4×	1.2k 2.8×	469 1.3×	26	3.3k
Lyn Harper Mozley United States	17	288 0.3×	632 1.0×	774 1.5×	260 0.6×	674 1.9×	27	2.2k
Pierre Étienne Canada	25	795 0.8×	357 0.6×	516 1.0×	570 1.3×	301 0.8×	57	2.0k
Gabriel C. Léger United States	21	360 0.4×	518 0.8×	532 1.0×	406 0.9×	400 1.1×	43	2.0k
D. Larry Sparks United States	22	468 0.5×	291 0.5×	1.2k 2.3×	419 0.9×	183 0.5×	41	2.4k

Countries citing papers authored by C H van Dyck

Since Specialization

Citations

This map shows the geographic impact of C H van Dyck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C H van Dyck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C H van Dyck more than expected).

Fields of papers citing papers by C H van Dyck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C H van Dyck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C H van Dyck. The network helps show where C H van Dyck may publish in the future.

Co-authorship network of co-authors of C H van Dyck

This figure shows the co-authorship network connecting the top 25 collaborators of C H van Dyck. A scholar is included among the top collaborators of C H van Dyck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C H van Dyck. C H van Dyck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hui, Amy Leung, Jennifer M. Yamamoto, Vanessa Poliquin, et al.. (2025). Impact of discontinuation of lactation consultant program on early infant feeding in Manitoba. International Breastfeeding Journal. 20(1). 42–42.

Lanctôt, Krista L., Roberta W. Scherer, Abby Li, et al.. (2020). Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. American Journal of Geriatric Psychiatry. 29(1). 81–89. 12 indexed citations

Sano, Mary, Karen L. Bell, Douglas Galasko, et al.. (2011). A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 77(6). 556–563. 244 indexed citations

Harrington, Conn, Sharon Sawchak, Carl Chiang, et al.. (2011). Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies. Current Alzheimer Research. 8(5). 592–606. 157 indexed citations

Salloway, Stephen, Reisa A. Sperling, Ron Keren, et al.. (2011). A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology. 77(13). 1253–1262. 203 indexed citations

Sevigny, Jeffrey, et al.. (2008). Growth hormone secretagogue MK-677. Neurology. 71(21). 1702–1708. 73 indexed citations

Seibyl, John, Kenneth Marek, Sami S. Zoghbi, et al.. (1998). Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.. PubMed. 39(9). 1500–8. 128 indexed citations

Seibyl, John, Kenneth Marek, R.M. Baldwin, et al.. (1997). Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.. PubMed. 38(9). 1453–9. 81 indexed citations

Laruelle, Marc, Anissa Abi‐Dargham, C H van Dyck, et al.. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.. Proceedings of the National Academy of Sciences. 93(17). 9235–9240. 980 indexed citations breakdown →

10.

Laruelle, Marc, Anissa Abi‐Dargham, C H van Dyck, et al.. (1995). SPECTImagingof StriatalDopamineRelease after Amphetamine Challenge. 1 indexed citations

11.

Laruelle, Marc, Anissa Abi‐Dargham, C H van Dyck, et al.. (1995). SPECT imaging of striatal dopamine release after amphetamine challenge.. PubMed. 36(7). 1182–90. 267 indexed citations

12.

Laruelle, Marc, Anissa Abi‐Dargham, C H van Dyck, et al.. (1995). Spect imaging of striatal dopamine release after amphetamine challenge in humans: Relationship between subjective effects and dopamine release. Schizophrenia Research. 15(1-2). 89–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact